A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more:
Posts tagged as
Alzheimer’s Disease
Alzheimer’s disease: The right drug, the right time
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer’s therapies and the road ahead.
UF-led consortium aims to accelerate Alzheimer’s research and treatment
MBI and 1Florida ADRC Director Todd Golde, M.D., Ph.D., shines light on UF’s role in a nationwide initiative to combat the disease and his hopes for the future
Research Snapshots: Drs. Michael Pace & David Borchelt
Study demonstrates that additional proteins misfold in the presence of neurodegenerative disease pathologies.
MBI Director Dr. Todd Golde discusses dementia
Following Sandra Day O’Connor’s announcement of her dementia, and possibly Alzheimer’s, diagnosis, Dr. Todd Golde explains a dementia diagnosis, current treatments and his hope for the future.
MBI researchers identify potential strategy to treat Alzheimer’s disease
A mouse-model study led by Drs. Paramita Chakrabarty and Todd Golde describes how their team bioengineered a naturally occurring protein to enable it to bind to amyloid beta protein in the brain.
Harnessing the power of the hub
MBI members discuss how the service and science hub specialty care model is working at the Fixel Center.
Research Snapshots: Drs. Abbi Hernandez & Sara Burke
The vulnerability of particular brain regions in old age that are important for problem-solving and reasoning.
Potential alternatives and new perspectives in Alzheimer’s treatments
Glenn Smith, Ph.D., ABPP-cn, chair of the department of clinical and health psychology, recently commented on the state of Alzheimer’s disease research in a Citrus County Chronicle feature story.
Researchers talk Alzheimer’s findings on Reddit
Visit Drs. Todd Golde and Brenda Moore’s Reddit Science AMA from Jan. 31, where they answered questions about the future of Alzheimer’s research.